Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology.

Hirsch AJ, Roberts VHJ, Grigsby PL, Haese N, Schabel MC, Wang X, Lo JO, Liu Z, Kroenke CD, Smith JL, Kelleher M, Broeckel R, Kreklywich CN, Parkins CJ, Denton M, Smith P, DeFilippis V, Messer W, Nelson JA, Hennebold JD, Grafe M, Colgin L, Lewis A, Ducore R, Swanson T, Legasse AW, Axthelm MK, MacAllister R, Moses AV, Morgan TK, Frias AE, Streblow DN.

Nat Commun. 2018 Jan 17;9(1):263. doi: 10.1038/s41467-017-02499-9.

2.

Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.

Garrigues HJ, Howard K, Barcy S, Ikoma M, Moses AV, Deutsch GH, Wu D, Ueda K, Rose TM.

J Virol. 2017 Nov 30;91(24). pii: e01532-17. doi: 10.1128/JVI.01532-17. Print 2017 Dec 15.

3.

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus.

McAllister SC, Hanson RL, Grissom KN, Botto S, Moses AV.

J Vis Exp. 2017 Aug 25;(126). doi: 10.3791/54828.

4.

The Heme Metabolite Carbon Monoxide Facilitates KSHV Infection by Inhibiting TLR4 Signaling in Endothelial Cells.

Botto S, Gustin JK, Moses AV.

Front Microbiol. 2017 Apr 3;8:568. doi: 10.3389/fmicb.2017.00568. eCollection 2017.

5.

Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms.

Botto S, Totonchy JE, Gustin JK, Moses AV.

mBio. 2015 Jun 4;6(3):e00668. doi: 10.1128/mBio.00668-15.

6.

Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.

Gustin JK, Bai Y, Moses AV, Douglas JL.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S181-90. doi: 10.1093/infdis/jiv125. Epub 2015 Mar 27.

7.

CXCR7 expression disrupts endothelial cell homeostasis and causes ligand-dependent invasion.

Totonchy JE, Clepper L, Phillips KG, McCarty OJ, Moses AV.

Cell Adh Migr. 2014;8(2):165-76.

9.

Aberrant proliferation in CXCR7+ endothelial cells via degradation of the retinoblastoma protein.

Totonchy JE, Osborn JM, Botto S, Clepper L, Moses AV.

PLoS One. 2013 Jul 23;8(7):e69828. doi: 10.1371/journal.pone.0069828. Print 2013.

10.

A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.

Douglas JL, Bai Y, Gustin JK, Moses AV.

Virology. 2013 Jul 5;441(2):182-96. doi: 10.1016/j.virol.2013.03.015. Epub 2013 Apr 10.

11.

IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling.

Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M Jr, Früh K, Diamond MS.

PLoS Pathog. 2013 Jan;9(1):e1003118. doi: 10.1371/journal.ppat.1003118. Epub 2013 Jan 3. Erratum in: PLoS Pathog. 2013 May;9(5). :10.1371/annotation/4de7ddfd-52df-4f87-8ca4-d48afe646ca8.

12.

CD31 immunohistochemical staining in Kaposi Sarcoma.

Pantanowitz L, Moses AV, Früh K.

Arch Pathol Lab Med. 2012 Nov;136(11):1329; author reply 1330. doi: 10.5858/arpa.2012-0153-LE. No abstract available.

PMID:
23106575
13.

Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain.

Gustin JK, Douglas JL, Bai Y, Moses AV.

J Biol Chem. 2012 Apr 27;287(18):14837-50. doi: 10.1074/jbc.M112.349928. Epub 2012 Mar 1.

14.

Viral takeover of the host ubiquitin system.

Gustin JK, Moses AV, Früh K, Douglas JL.

Front Microbiol. 2011 Jul 28;2:161. doi: 10.3389/fmicb.2011.00161. eCollection 2011.

15.

Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21.

Sugaya M, Reed S, Rose PP, de la Motte S, Raggo CM, Kurtz SE, Moses AV, Früh K, Blauvelt A.

J Dermatol Sci. 2011 Feb;61(2):139-42. doi: 10.1016/j.jdermsci.2010.11.017. Epub 2010 Dec 5. No abstract available.

16.

The great escape: viral strategies to counter BST-2/tetherin.

Douglas JL, Gustin JK, Viswanathan K, Mansouri M, Moses AV, Früh K.

PLoS Pathog. 2010 May 13;6(5):e1000913. doi: 10.1371/journal.ppat.1000913. Review.

17.

Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.

Douglas JL, Gustin JK, Moses AV, Dezube BJ, Pantanowitz L.

Transl Biomed. 2010;1(2). pii: 172.

18.

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.

Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, Moses AV, Früh K.

J Virol. 2009 Oct;83(19):9672-81. doi: 10.1128/JVI.00597-09. Epub 2009 Jul 15.

19.

The inflammatory component of Kaposi sarcoma.

Pantanowitz L, Moses AV, Dezube BJ.

Exp Mol Pathol. 2009 Oct;87(2):163-5. doi: 10.1016/j.yexmp.2009.07.001. Epub 2009 Jul 8. Review.

PMID:
19591823
20.

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.

Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, Moses AV.

J Virol. 2009 Aug;83(16):7931-47. doi: 10.1128/JVI.00242-09. Epub 2009 Jun 10.

21.

Characterization of c-Kit expression and activation in KSHV-infected endothelial cells.

Douglas JL, Whitford JG, Moses AV.

Virology. 2009 Aug 1;390(2):174-85. doi: 10.1016/j.virol.2009.05.011. Epub 2009 Jun 6.

22.

Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Mansouri M, Rose PP, Moses AV, Früh K.

J Virol. 2008 Oct;82(19):9615-28. doi: 10.1128/JVI.02633-07. Epub 2008 Jul 30.

23.

Pathology of rituximab-induced Kaposi sarcoma flare.

Pantanowitz L, Früh K, Marconi S, Moses AV, Dezube BJ.

BMC Clin Pathol. 2008 Jul 23;8:7. doi: 10.1186/1472-6890-8-7.

24.

Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing.

Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA.

Curr Top Microbiol Immunol. 2008;325:397-415. Review.

25.

Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing.

Dumortier J, Streblow DN, Moses AV, Jacobs JM, Kreklywich CN, Camp D, Smith RD, Orloff SL, Nelson JA.

J Virol. 2008 Jul;82(13):6524-35. doi: 10.1128/JVI.00502-08. Epub 2008 Apr 30.

26.

Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma.

Smith JR, Henderson WW, Rosenbaum JT, Neuwelt EA, Moses AV.

Br J Ophthalmol. 2008 Feb;92(2):297-9. doi: 10.1136/bjo.2007.119461. No abstract available.

PMID:
18227216
27.

The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants.

Streblow DN, Kreklywich CN, Andoh T, Moses AV, Dumortier J, Smith PP, Defilippis V, Fruh K, Nelson JA, Orloff SL.

Am J Transplant. 2008 Feb;8(2):277-87. Epub 2007 Dec 18.

28.

Kaposi's sarcoma: a model of both malignancy and chronic inflammation.

Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV.

Panminerva Med. 2007 Sep;49(3):119-38. Review.

PMID:
17912148
30.

Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.

McAllister SC, Moses AV.

Curr Top Microbiol Immunol. 2007;312:211-44. Review.

PMID:
17089799
31.

The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma.

Rose PP, Carroll JM, Carroll PA, DeFilippis VR, Lagunoff M, Moses AV, Roberts CT Jr, Früh K.

Oncogene. 2007 Mar 29;26(14):1995-2005. Epub 2006 Sep 25.

PMID:
17001305
32.

Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells.

Mansouri M, Douglas J, Rose PP, Gouveia K, Thomas G, Means RE, Moses AV, Früh K.

Blood. 2006 Sep 15;108(6):1932-40. Epub 2006 Apr 6.

33.

Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma.

McAllister SC, Früh K, Moses AV.

Pharmacogenomics. 2005 Apr;6(3):235-44. Review.

PMID:
16013955
34.

Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Raggo C, Ruhl R, McAllister S, Koon H, Dezube BJ, Früh K, Moses AV.

Cancer Res. 2005 Jun 15;65(12):5084-95.

35.

Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase.

McAllister SC, Hansen SG, Messaoudi I, Nikolich-Zugich J, Moses AV.

J Virol. 2005 Feb;79(4):2626-30.

36.
37.

Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells.

McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Früh K, Moses AV.

Blood. 2004 May 1;103(9):3465-73. Epub 2004 Jan 15.

PMID:
14726403
38.

A functional genomics approach to Kaposi's sarcoma.

Moses AV, Jarvis MA, Raggo C, Bell YC, Ruhl R, Luukkonen BG, Griffith DJ, Wait CL, Druker BJ, Heinrich MC, Nelson JA, Fruh K.

Ann N Y Acad Sci. 2002 Dec;975:180-91.

PMID:
12538164
39.

Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.

Moses AV, Jarvis MA, Raggo C, Bell YC, Ruhl R, Luukkonen BG, Griffith DJ, Wait CL, Druker BJ, Heinrich MC, Nelson JA, Früh K.

J Virol. 2002 Aug;76(16):8383-99.

40.

Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus.

Zoeteweij JP, Moses AV, Rinderknecht AS, Davis DA, Overwijk WW, Yarchoan R, Orenstein JM, Blauvelt A.

Blood. 2001 Apr 15;97(8):2374-80.

PMID:
11290600
41.

Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.

Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL.

Am J Pathol. 1999 Dec;155(6):1915-27.

42.

Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.

Moses AV, Fish KN, Ruhl R, Smith PP, Strussenberg JG, Zhu L, Chandran B, Nelson JA.

J Virol. 1999 Aug;73(8):6892-902.

43.

HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas.

Moses AV, Williams SE, Strussenberg JG, Heneveld ML, Ruhl RA, Bakke AC, Bagby GC, Nelson JA.

Nat Med. 1997 Nov;3(11):1242-9.

PMID:
9359699
44.

Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells.

Prudhomme JG, Sherman IW, Land KM, Moses AV, Stenglein S, Nelson JA.

Int J Parasitol. 1996 Jun;26(6):647-55.

PMID:
8875310
45.
46.

Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors.

Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, Loveless M, Bagby G, Nelson JA.

Blood. 1996 Feb 1;87(3):919-25.

PMID:
8562963
47.

HIV infection of the brain microvasculature and its contribution to the AIDS dementia complex.

Moses AV, Stenglein SG, Nelson JA.

J NeuroAIDS. 1996;1(1):85-99. Review. No abstract available.

PMID:
16873156
48.

Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages.

Fish KN, Depto AS, Moses AV, Britt W, Nelson JA.

J Virol. 1995 Jun;69(6):3737-43.

50.

HIV infection of human brain capillary endothelial cells--implications for AIDS dementia.

Moses AV, Nelson JA.

Adv Neuroimmunol. 1994;4(3):239-47. Review.

PMID:
7533040

Supplemental Content

Loading ...
Support Center